RegentAtlantic Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.18M | Buy |
|
|||||
|
2022
Q2 | $2.1M | Buy |
|
|||||
|
2022
Q1 | $1.99M | Sell |
|
|||||
|
2021
Q4 | $2.54M | Buy |
|
|||||
|
2021
Q3 | $2.38M | Buy |
|
|||||
|
2021
Q2 | $2.27M | Buy |
|
|||||
|
2021
Q1 | $2.07M | Buy |
|
|||||
|
2020
Q4 | $1.74M | Sell |
|
|||||
|
2020
Q3 | $3.25M | Sell |
|
|||||
|
2020
Q2 | $6.72M | Buy |
|
|||||
|
2020
Q1 | $3.13M | Buy |
|
|||||
|
2019
Q4 | $2.56M | Sell |
|
|||||
|
2019
Q3 | $3.07M | Buy |
|
|||||
|
2019
Q2 | $3.15M | Buy |
|
|||||
|
2019
Q1 | $2.77M | Buy |
|
|||||
|
2018
Q4 | $2.11M | Sell |
|
|||||
|
2018
Q3 | $3.39M | Sell |
|
|||||
|
2018
Q2 | $3.79M | Sell |
|
|||||
|
2018
Q1 | $4.51M | Buy |
|
|||||
|
2017
Q4 | $4.16M | Buy |
|
|||||
|
2017
Q3 | $4.45M | Buy |
|
|||||
|
2017
Q2 | $3.77M | Buy |
|
|||||
|
2017
Q1 | $3.53M | Buy |
|
|||||
|
2016
Q4 | $3.06M | Sell |
|
|||||
|
2016
Q3 | $4.61M | Buy |
|
|||||
|
2016
Q2 | $4.71M | Buy |
|
|||||
|
2016
Q1 | $4.38M | Sell |
|
|||||
|
2015
Q4 | $5.26M | Buy |
|
|||||
|
2015
Q3 | $2.56M | Buy |
|
|||||
|
2015
Q2 | $702K | Buy |
|
|||||
|
2015
Q1 | $571K | Buy |
|
|||||
|
2014
Q4 | $544K | Sell |
|
|||||
|
2014
Q3 | $699K | Buy |
|
|||||
|
2014
Q2 | $467K | Buy |
|
|||||
|
2014
Q1 | $218K | Buy |
|
|||||
|
2013
Q4 | $215K | Buy |
|